“For Cause” Inspections Find Galloping Clinical Trial Violation Rate

The violation rate for clinical trial sponsors shot up in fiscal year 2007, hitting a 10-year high, with FDA finding many of the problems during inspections triggered by complaints, according to CDRH

More from Archive

More from Medtech Insight